Watch Now: Establishing Evidence – New Advancements Using ctDNA
Play Video On July 11, 2023, Friends of Cancer Research (Friends) hosted, “Establishing Evidence: New Advancements Using ctDNA”, a public meeting in Washington, DC. The meeting included data readouts...
View ArticleClik here to view.
Quarterly Advocacy Newsletter – Q3 2023
Dear Advocates,Welcome to the third edition of the Friends of Cancer Research (Friends) Quarterly Advocacy Newsletter. We’re excited to share more about what we’ve been working on at Friends and let...
View ArticleWatch Now: Supporting the Use of RWD in Oncology Drug Development
Play Video On September 11, 2023, Friends of Cancer Research (Friends) hosted a public meeting, “Supporting the Use of RWD in Oncology Drug Development”, in Washington, DC. The meeting included a...
View ArticleClik here to view.
Watch Now: Future in Focus: Digital Pathology in Oncology Drug Development
Play Video On September 26th, Friends of Cancer Research (Friends) hosted, “Future in Focus: Digital Pathology in Oncology Drug Development,” a virtual public meeting to discuss the opportunities,...
View ArticleWatch Now: Friends of Cancer Research Annual Meeting 2023
Play Video On November 14, 2023, Friends of Cancer Research (Friends) hosted our 16th Annual Meeting in Washington, D.C. Discussions at the meeting were the culmination of three working groups led by...
View ArticleClik here to view.
Quarterly Advocacy Newsletter – Q4 2023
Dear Advocates,We are excited to welcome you to the fourth edition of the Friends Advocacy Newsletter. It has been a great year working with you to create and launch this resource and we want to hear...
View ArticleWatch Now: Enhancing Diversity in Clinical Trials: Implementation of...
/*! elementor - v3.20.0 - 26-03-2024 */ .elementor-widget-video .elementor-widget-container{overflow:hidden;transform:translateZ(0)}.elementor-widget-video...
View ArticleClik here to view.
Critical Findings from Friends HRD Harmonization Project
Homologous Recombination Deficiency (HRD) is a complex biomarker that can help identify patients likely to respond to certain therapies. Friends of Cancer Research’s (Friends) HRD Harmonization...
View ArticleClik here to view.
Quarterly Advocacy Newsletter – Q1 2024
Welcome to Friends’ first Quarterly Patient Advocate Newsletter of 2024. 2023 Advocacy Newsletters Newsletter Feedback Form Here’s what you can read more about in this newsletter:What’s Happening at...
View ArticleClik here to view.
Digital PATH Project looks to the future of oncology
/*! elementor - v3.20.0 - 26-03-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a...
View ArticleWatch Now: Unlocking Complex Cell-Based Gene Therapies
/*! elementor - v3.21.0 - 08-05-2024 */ .elementor-widget-video .elementor-widget-container{overflow:hidden;transform:translateZ(0)}.elementor-widget-video...
View ArticleClik here to view.
Assessing the Impact of the Research to Accelerate Cures and Equity (RACE) Act
/*! elementor - v3.21.0 - 22-05-2024 */ .elementor-widget-text-editor.elementor-drop-cap-view-stacked...
View ArticleWatch Now: Friends’ Cell Therapies Webinar for Advocates
/*! elementor - v3.21.0 - 26-05-2024 */ .elementor-widget-video .elementor-widget-container{overflow:hidden;transform:translateZ(0)}.elementor-widget-video...
View ArticleClik here to view.
Friends’ Advocate Insights: Chris White’s Experience with TIL Therapy and His...
Chris White, Author of “Killing Cancer with TILs” and Patient Advocate Chris White is a passionate advocate for cell therapies. He spends his time collaborating with patient advocacy groups,...
View ArticleClik here to view.
Quarterly Advocacy Newsletter – Q2 2024
Welcome to Friends’ second Quarterly Advocacy Newsletter of 2024. In Q2, Friends co-hosted a public meeting about cell therapies with the Parker Institute for Cancer Immunotherapy, published several...
View ArticleClik here to view.
Congressional Hearing Focuses on Key Issues Facing FDA and the Future of...
/*! elementor - v3.21.0 - 26-05-2024 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a...
View ArticleClik here to view.
Stakeholder Connect | Insights from the July 25, 2024 Meeting of the Oncology...
/*! elementor - v3.23.0 - 05-08-2024 */ .elementor-widget-text-editor.elementor-drop-cap-view-stacked...
View ArticleProject Pulse | Bridging research and practice: enhancing regulatory...
/*! elementor - v3.23.0 - 05-08-2024 */ .elementor-widget-text-editor.elementor-drop-cap-view-stacked...
View ArticleStakeholder Connect | Supreme Court Decisions and Their Impact on the FDA and...
/*! elementor - v3.23.0 - 05-08-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading...
View ArticleClik here to view.
Quarterly Advocacy Newsletter – Q3 2024
Welcome to Friends’ third Quarterly Advocacy Newsletter of 2024. In Q3, Friends published several peer-reviewed manuscripts with insights on enhancing representation in clinical trials, use of RWD to...
View Article